{"id":61456,"date":"2025-06-19T22:03:04","date_gmt":"2025-06-19T20:03:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/"},"modified":"2025-06-19T22:03:04","modified_gmt":"2025-06-19T20:03:04","slug":"mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/","title":{"rendered":"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting"},"content":{"rendered":"<div>\n<p>ATLANTA&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mirion.com&amp;esheet=54279723&amp;newsitemid=20250619927229&amp;lan=en-US&amp;anchor=Mirion&amp;index=1&amp;md5=edabdb5aba1aca4b1e7318637241fd3e\" rel=\"nofollow\" shape=\"rect\">Mirion<\/a>, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec and Dosimetry Services will be introduced alongside innovations from the broader Mirion portfolio, including the ec<sup>2<\/sup> Software suite and advances from Mirion Technologies.<\/p>\n<p>\n<b>Debuting at the 2025 SNMMI Annual Meeting<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Graves Phantom from Capintec, a Mirion Medical company:<\/b> The Graves Phantom is a groundbreaking, solution for enabling precise dosimetry in radiopharmaceutical therapy (RPT). Designed as a 20-cm tissue-equivalent phantom, it supports the calibration of SPECT systems per radioisotope and allows for accurate sensitivity factor measurements under realistic scatter conditions, enabling reliable and reproducible RPT workflows.<\/li>\n<li>\n<b>Instadose<sup>\u00ae<\/sup>VUE Beta Dosimeter from Dosimetry Services, a Mirion Medical company:<\/b> The only hybrid wireless dosimeter designed for theranostic applications, the InstadoseVUE Beta device tracks and measures radiation exposure, ensuring the safety of medical staff in environments where beta radiation is present. The InstadoseVUE Beta is the latest model in the InstadoseVUE line of wireless dosimeters for radiation monitoring of personnel.<\/li>\n<\/ul>\n<p>\n<b>Additional Featured Solutions from the Broader Mirion Portfolio<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>ec<sup>2<\/sup> Software Suite:<\/b> ec<b><sup>2<\/sup><\/b> Software, a Mirion Medical company, provides software to simplify workflows, support regulatory compliance, and drive operational efficiency for stakeholders across the nuclear medicine, molecular imaging and radiopharmaceutical fields\u200b\u200b. Demonstrations for applications including BioTrax\u2122 QMS, NMIS\u2122, and BioRx\u2122 will be available throughout the SNMMI Annual Meeting.<\/li>\n<li>\n<b>Apex-Guard\u2122 Software:<\/b> From Mirion Technologies, the newest version of Apex-Guard software includes a robust impurity analysis feature and patent-pending algorithm for gamma spectroscopy measurements, which simplifies radioisotope production quality management, boosts confidence in radioisotope safety, and aids in regulatory compliance. The software integrates with BioTrax QMS, improving workflow efficiency and data integrity.<\/li>\n<li>\n<b>Portable and Mobile Radiation Monitoring: <\/b>New solutions from Mirion Technologies include the CSPevo<sup>\u00ae<\/sup> Probe and RDS-Med\u2122 Survey Meter for comprehensive, portable radiation survey monitoring and the IC3\u2122 Portable Ion Chamber Survey Meter for measuring gamma, beta and X-ray radiation. In addition, the iCAM\u2122 Mobile Alpha\/Beta Particulate Monitor for reliable monitoring of airborne activity will be on hand.<\/li>\n<\/ul>\n<p>\n\u201cAs the nuclear medicine and molecular imaging landscape evolves, Mirion is committed to leveraging our deep expertise in ionizing radiation to serve our customers and ensure safe, efficient operations at every step,\u201d said Luis Rivera, Executive Vice President of Mirion Medical. \u201cFrom research to production to patient care, Mirion Medical and Mirion Technologies alike are developing solutions to drive higher quality. We look forward to demonstrating how these solutions can shape a more connected future.\u201d<\/p>\n<p>\n<b>Commitment to Patient Care and Safety<br \/>\n<br \/><\/b>Mirion Medical is a proud sponsor of the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsnmmi.org%2FWeb%2FEducation-and-Meetings%2FPatient_Education_Day.aspx&amp;esheet=54279723&amp;newsitemid=20250619927229&amp;lan=en-US&amp;anchor=SNMMI+2025+Patient+Education+Day&amp;index=2&amp;md5=dd78fa268571f400a8d8d8228469a35a\" rel=\"nofollow\" shape=\"rect\">SNMMI 2025 Patient Education Day<\/a>, contributing educational resources and insights on radiation safety. This sponsorship reflects Mirion&#8217;s commitment to patient education and awareness, ensuring that patients and their families are well-informed about the benefits of nuclear medicine and molecular imaging.<\/p>\n<p>\n<b>About Mirion<br \/>\n<br \/><\/b>Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. The Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA \u2013 USA), Mirion employs approximately 2,800 people and operates in 12 countries.<\/p>\n<p>\n\u00a92025 Mirion. All rights reserved. Instadose\u00aeVUE, BioTrax\u2122 QMS, NMIS\u2122, BioRx\u2122, CSPevo\u2122, Apex-Guard\u2122, IC3\u2122, and iCAM\u2122 are trademarks or registered trademarks of Mirion Technologies, Inc. and\/or its affiliates in the United States and\/or other countries.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<i>For media inquiries:<\/i><br \/>Erin Schesny<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;&#111;&#x3a;&#109;&#x65;&#100;i&#x61;&#64;&#x6d;&#105;&#x72;&#105;&#x6f;&#110;&#x2e;&#99;o&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#109;&#x65;d&#105;&#x61;&#64;&#109;&#x69;r&#105;&#x6f;n&#46;&#x63;o&#109;<\/a><\/p>\n<p>\n<i>For investor inquiries:<\/i><br \/>Eric Linn<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#111;&#x3a;&#x69;&#x72;&#x40;&#x6d;ir&#105;&#111;&#110;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#105;&#x72;&#64;&#109;&#x69;&#114;&#x69;o&#110;&#x2e;c&#x6f;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA&#8211;(BUSINESS WIRE)&#8211;Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61456","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ATLANTA&#8211;(BUSINESS WIRE)&#8211;Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-19T20:03:04+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting\",\"datePublished\":\"2025-06-19T20:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/\"},\"wordCount\":657,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/\",\"name\":\"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-06-19T20:03:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting - Pharma Trend","og_description":"ATLANTA&#8211;(BUSINESS WIRE)&#8211;Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2025-06-19T20:03:04+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting","datePublished":"2025-06-19T20:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/"},"wordCount":657,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/","name":"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-06-19T20:03:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mirion-medical-to-debut-new-solutions-highlight-broad-radiopharma-focused-portfolio-at-snmmi-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61456"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61456\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}